SG52340A1 - Antitumor mitoxantrone polymeric compositions - Google Patents

Antitumor mitoxantrone polymeric compositions

Info

Publication number
SG52340A1
SG52340A1 SG1996003102A SG1996003102A SG52340A1 SG 52340 A1 SG52340 A1 SG 52340A1 SG 1996003102 A SG1996003102 A SG 1996003102A SG 1996003102 A SG1996003102 A SG 1996003102A SG 52340 A1 SG52340 A1 SG 52340A1
Authority
SG
Singapore
Prior art keywords
antitumor
mitoxantrone
polymeric compositions
compositions
mve
Prior art date
Application number
SG1996003102A
Other languages
English (en)
Inventor
Hwei-Ru Tsou
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of SG52340A1 publication Critical patent/SG52340A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
SG1996003102A 1993-03-25 1994-02-17 Antitumor mitoxantrone polymeric compositions SG52340A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/037,149 US5378456A (en) 1993-03-25 1993-03-25 Antitumor mitoxantrone polymeric compositions

Publications (1)

Publication Number Publication Date
SG52340A1 true SG52340A1 (en) 1998-09-28

Family

ID=21892713

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996003102A SG52340A1 (en) 1993-03-25 1994-02-17 Antitumor mitoxantrone polymeric compositions

Country Status (11)

Country Link
US (1) US5378456A (de)
EP (1) EP0616813B1 (de)
JP (1) JPH06321927A (de)
KR (1) KR100348380B1 (de)
AT (1) ATE210996T1 (de)
CA (1) CA2119675A1 (de)
DE (1) DE69429468T2 (de)
DK (1) DK0616813T3 (de)
ES (1) ES2169049T3 (de)
PT (1) PT616813E (de)
SG (1) SG52340A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030203976A1 (en) 1993-07-19 2003-10-30 William L. Hunter Anti-angiogenic compositions and methods of use
ATE420628T1 (de) * 1993-07-19 2009-01-15 Angiotech Pharm Inc Anti-angiogene mittel und verfahren zu deren verwendung
US5609867A (en) 1994-11-01 1997-03-11 American Cyanamid Company Polymeric antitumor agents
US6624317B1 (en) 2000-09-25 2003-09-23 The University Of North Carolina At Chapel Hill Taxoid conjugates as antimitotic and antitumor agents
BR0114713A (pt) * 2000-10-16 2004-01-13 Neopharm Inc Formulação lipossÈmica de mitoxantrona
GB0123232D0 (en) * 2001-09-26 2001-11-21 Smith & Nephew Polymers
US7939054B2 (en) * 2006-10-27 2011-05-10 Giuseppe Trigiante Compositions for removing hair
KR20160104612A (ko) 2013-07-26 2016-09-05 업데이트 파마 인코포레이트 비산트렌의 치료 효과 개선용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182800A (en) * 1977-07-16 1980-01-08 Hercules Incorporated Methotrexate-divinyl ether--maleic anhydride copolymer reaction product
JPS6067490A (ja) * 1983-09-24 1985-04-17 Agency Of Ind Science & Technol アントラサイクリン系抗生物質誘導体及びその製造方法
JPS6067426A (ja) * 1983-09-24 1985-04-17 Agency Of Ind Science & Technol 低毒性制ガン剤
US4520162A (en) * 1983-09-24 1985-05-28 Director-General Of The Agency Of Industrial Science & Technology Polymeric compounds with sustained anti-tumor activity and a method for the preparation thereof
GB8413464D0 (en) * 1984-05-25 1984-07-04 Erba Farmitalia Anthracycline-anionic polymer conjugates
KR950013762B1 (en) * 1986-10-07 1995-11-15 Boehringer Mannheim Italia Pharmaceutical compositions having antineoplastic activity
PT93772A (pt) * 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer
JPH0762049B2 (ja) * 1991-03-18 1995-07-05 工業技術院長 高分子マイトマイシンc誘導体及びその製造方法
JP3069646B2 (ja) * 1991-05-28 2000-07-24 三共株式会社 5−フルオロウリジン−高分子複合体

Also Published As

Publication number Publication date
DK0616813T3 (da) 2002-04-15
PT616813E (pt) 2002-06-28
KR100348380B1 (ko) 2004-03-25
DE69429468T2 (de) 2002-08-14
CA2119675A1 (en) 1994-09-26
KR940021068A (ko) 1994-10-17
ES2169049T3 (es) 2002-07-01
JPH06321927A (ja) 1994-11-22
EP0616813A3 (de) 1995-03-29
EP0616813B1 (de) 2001-12-19
US5378456A (en) 1995-01-03
DE69429468D1 (de) 2002-01-31
ATE210996T1 (de) 2002-01-15
EP0616813A2 (de) 1994-09-28

Similar Documents

Publication Publication Date Title
AU578184B2 (en) Flame-retardant olefinic resin composition
AU1179795A (en) Improved immunogenic compositions against human gastrin 17
HK1012508A1 (en) Human growth hormone variants.
AU8458891A (en) A process for the preparation of carnosic acid and the use of the acid for its anticarcinogenic and antiviral properties
SG52340A1 (en) Antitumor mitoxantrone polymeric compositions
AU628095B2 (en) Chelants possessing ortho ligating functionality and complexes thereof
CA2120153A1 (en) Recombinant immunotoxins
ES8705012A1 (es) Un procedimiento para preparar una composicion para marcar carreteras
AU583624B2 (en) Polymers with pendant isocyanatocarbonyl groups, and their production processes, and compositions comprising them
AU7433691A (en) Polyketone polymer compositions
DE3362303D1 (en) Polycarbonates containing end groups with conjugated double bonds which may be mixed with known aromatic polycarbonates, process for their preparation and their uses
EP0237284A3 (de) Polyester-Zusammensetzung mit verbesserter Fliessfähigkeit
PL322103A1 (en) Benzopyraneindodiazolic anticaecinogenic agents
CA1271281A (en) Biocompatible material for treatment of tissular or organic defects
SU1522721A1 (ru) Композиция для защитных покрытий шинных резин